Paper Details

  1. Home
  2. Paper Details

Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.

Author: CammàC, FabbriA, FiorelloF, MarchesiniG, PagliaroL, TinèF

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Lactitol is as effective as other disaccharides in treating chronic hepatic encephalopathy, with fewer side effects and improved palatability.
Paper Details　
Original Abstract of the Article :
The efficacy and side effects of lactitol in the treatment of chronic hepatic encephalopathy was compared to that of other disaccharides in a meta-analysis of published randomized clinical trials (RCTs). The outcomes assessed were: (1) the rate of patients free from episodes of clinically detectable...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF01295920

データ提供：米国国立医学図書館（NLM）

Lactitol: A Refreshing Oasis in the Desert of Hepatic Encephalopathy

Hepatic encephalopathy, a serious condition affecting the brain in individuals with liver disease, is like a treacherous desert mirage, tempting but ultimately dangerous. This research explores the potential of lactitol as a therapeutic oasis for managing this challenging condition. The study reviewed published clinical trials comparing the efficacy of lactitol to other disaccharides in treating chronic hepatic encephalopathy. The findings suggest that lactitol might be a viable and well-tolerated alternative for managing this condition.

A Journey to Mental Clarity: Lactitol's Promise in Hepatic Encephalopathy

The study found that lactitol was as effective as other disaccharides in preventing episodes of encephalopathy. However, lactitol was associated with fewer side effects and was considered more palatable by patients. These findings suggest that lactitol could offer a more comfortable and acceptable treatment option for individuals with chronic hepatic encephalopathy.

Finding Balance in the Desert: Optimizing Treatment for Liver Disease

This research highlights the importance of optimizing treatment strategies for individuals with liver disease. The findings suggest that lactitol could offer a promising alternative to other disaccharides, providing a more tolerable and effective approach to managing chronic hepatic encephalopathy. However, further research is needed to fully evaluate its long-term efficacy and safety.

Dr. Camel's Conclusion

This research offers a potential oasis of hope for individuals struggling with hepatic encephalopathy. The findings suggest that lactitol might offer a viable and well-tolerated alternative for managing this challenging condition. This underscores the importance of continued research and development in the field of liver disease, as new and innovative treatments are crucial for improving the lives of patients with this complex condition.

Date :
  1. Date Completed 1993-06-02
  2. Date Revised 2019-07-21
Further Info :

Pubmed ID

8482191

DOI: Digital Object Identifier

10.1007/BF01295920

Related Literature

Article Analysis
・Side Effects of lactulose
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.